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Objective
Adenoma detection rate (ADR) is a recommended quality measure for screening colonoscopies in risk population. The main 
aim of our study was to calculate ADR in Vilnius University Hospital Santariskiu Klinikos (VUH SK) and determine inter­individ­
ual variations among practicing endoscopists. 
Material and methods
Retrospective data review of all the patients who underwent screening colonoscopy in the VUH SK (Vilnius, Lithuania) be­
tween 2009 and 2012. 
Results
A total of 1633 colonoscopies, which were performed by five practicing endoscopists were included. The overall cecal intu­
bation rate was 96.8%. Bowel preparation was good, medium and poor in 65.2%, 28.1% and 6.7% cases, respectively. Polyps 
were found more commonly in men rather than women: adenomas 40.4% vs. 24% (p<0.001), hyperplastic polyps 11.1% vs. 
6.6% (p=0.001), multiple adenomas 6.4% vs. 1.9% (p<0.001). Colorectal cancer was found in 76 patients (4.7%) and there was 
no statistically significant difference regarding sex (p=0.76). The overall ADR was 31.5%. ADR in men was statistically signifi­
cantly higher compared with ADR in women (40.4% vs. 24%; p<0.001). ADR ranged among endoscopists from 26.8% to 36.5% 
(p=0.007). Overall multiple adenoma detection rate was 4% and ranged among endoscopists from 1.7% to 6.7% (p=0.03). 
Mean number of adenoma per procedure was 0.5 and mean number of adenoma per positive procedure was 1.59.
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Conclusions
Adenoma detection rate in our center is high. Based on current recommendations ADR detected is sufficient for reporting 
high quality screening colonoscopy.
Key words: adenoma, adenomatous polyps, colon, colonoscopy, detection, colorectal neoplasms
Įvadas
Prevencinių kolonoskopijų kokybė vertinama apskaičiuojant adenomų radimo dažį (ARD). Mūsų tyrimo tikslas – apskaičiuoti 
prevencinių kolonoskopijų (storosios žarnos vėžio ankstyvosios diagnostikos programa) ARD ir kitus išvestinius kokybės ro­
diklius bei palyginti jų skirtumus tarp Vilniaus universiteto ligoninės Santariškių klinikų endoskopuotojų (VUL SK).
Metodai
Retrospektyvusis 2009–2012 metais VUL SK (Vilnius, Lietuva) atliktų prevencinių kolonoskopijų duomenų tyrimas.
Rezultatai
Į analizę buvo įtrauktos 1633 kolonoskopijos, kurias atliko 5 endoskopuotojai. Bendras aklosios žarnos intubacijos dažnis 
buvo 96,8%. Žarnynas tyrimui buvo paruoštas gerai 65,2% atvejų, vidutiniškai 28,1 % atvejų ir blogai 6,7 % atvejų. Polipai 
dažniau rasti vyrams nei moterims: adenomos 40,4 % vs. 24 % (p<0,001), hiperplaziniai polipai 11,1 % vs. 6,6 % (p=0,001), 
daugybinės adenomos 6,4  % vs. 1,9  % (p<0,001). Storosios žarnos vėžys buvo rastas 76 pacientams (4,6  %) ir statistiškai 
reikšmingai nesiskyrė tarp vyrų ir moterų grupių (p=0,76). Bendras ARD buvo 31,5 % ir jis statistiškai reikšmingai buvo dides­
nis vyrų nei moterų grupėje: 40,4 % vs. 24 % (p<0,001). Tarp endoskopuotojų ARD svyravo nuo 26,8 % iki 36,5 % (p=0,007). 
Bendras daugybinių adenomų radimo dažnis buvo 4 % ir tarp endoskopuotojų svyravo nuo 1,7 % iki 6,7 % (p=0,03). Vidutinis 
adenomų skaičius procedūros metu buvo 0,5, o vidutinis adenomų skaičius teigiamos procedūros metu – 1,59.
Išvados
Adenomų radimo atliekant prevencines kolonoskopijas VUL SK dažnis yra didelis ir atitinka rekomenduojamus kokybės stan­
dartus.
Reikšminiai žodžiai: adenoma, polipai, kolonoskopija, kolorektalinis vėžys
Introduction
Colorectal cancer (CRC) is one of the major causes of 
morbidity and mortality in Lithuania as well as in the 
whole world. It accounts for 10.6% of all cancers cases 
in Lithuania [1]. Colonoscopy is effective in reducing 
CRC incidence and mortality [2] by endoscopic polyp-
ectomy, which removes benign adenomatous polyps be-
fore they progress and become neoplastic [3]. However, 
there are some limitations of colonoscopy as diagnostic 
procedure. It is estimated that up to 25% of polyps are 
missed during procedure [4]. Van Rijn et al [5] reported 
miss rates of 21% for very small (≤5mm), 13% for small 
(6-9mm) and 2% for large (≥10mm) adenomas. Also 
up to 8% of CRCs occur within 3 years after a previ-
ous colonoscopy and this cancer is known as interval or 
post-colonoscopic cancer [6-7]. Studies show that these 
CRCs are more likely due to missed lesions, rather than 
being new lesions [8]. 
Adenoma detection rate (ADR) is the proportion 
of screening colonoscopies performed by an endosco-
pist that detect at least one histologically confirmed 
adenoma [9]. ADR is a recommended quality measure 
for screening colonoscopies. It is known that optimal 
adenoma detection rate correlates with reduced rates 
of interval colorectal cancer following screening colo-
noscopy. Currently, societies recommends ADR of 
25% for all patients and rates of 20% for women and 
30% for men undergoing screening colonoscopy [10]. 
Large study from Poland has concluded, that adenoma 
detection rate is an independent predictor of the risk of 
interval colorectal cancer after screening colonoscopy 
and has validated a recommended ADR of 20% [11]. 
Recently, a large study also examined an impact of ADR 
on interval cancer: for each 1% increase in ADR, there 
was an associated 3% reduction in the risk of cancer 
[12]. The lowest risk for interval cancer in the latter 
study was for those endoscopists with ADRs of at least 
33.5%. ADR is the most commonly used quality indica-
tor for screening colonoscopy. Also some supplemental 
measurements such as multiple adenoma detection rate, 
mean number of adenoma per procedure, mean number 
of adenoma per positive procedure has been proposed.
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ADR varies among endoscopists, so suboptimal 
performance is an important factor in the failure of 
colonoscopy to identify and prevent CRC [13]. Studies 
found, that ADR range from 3 to 6 times (including 
large adenomas) among different endoscopists [14]. 
The aim of our study was to calculate ADR and sup-
plemental quality indicators for screening colonoscopies 
in VUH SK and determine inter-individual variations 
among our endoscopists.
Patients and methods.
All the patients, who underwent screening colonos-
copy (national colorectal cancer prevention program) 
at VUH SK Department of endoscopic diagnostics and 
minimally invasive surgery between January 2009 and 
December 2012, were included in the present study. 
Data were collected retrospectively from colonoscopy 
and pathology reports. The inclusion criteria were as 
follows: patients of 50–74 years old, positive fecal occult 
blood test, first time screening colonoscopy. The exclu-
sion criteria were as follows: a history of colonoscopy and 
diagnosis of colorectal pathology, a history of colorectal 
cancer, a history of colorectal surgery, endoscopist who 
performed less than 30 screening colonoscopies during 
the study period. Data collected included: demographic 
data (patient age, sex), bowel preparation quality, cecal 
intubation rate, findings and polyps detected, patho-
logical type of the polyps. We have calculated overall and 
individual measurements for each endoscopist. Specific 
definitions of all measurements are detailed in Table 1. 
Statistical analysis was performed using SPSS Statis-
tics version 20.0 and Microsoft Ofce 2013. The chi-
square test was used to compare ADR, FDR, MADR, 
cecal intubation rate between sex groups and among en-
doscopists. The differences in ADR, FDR and MADR 
between endoscopists were evaluated comparing the 
highest value (the endoscopist with the highest ADR, 
FDR or MADR) with the each other value. ANOVA 
was used for calculation of MAP and MAP+ among en-
doscopists. A p-value <0.05 was considered to indicate 
statistically significant differences.
Results
Between January 2009 and December 2012, 1658 
persons underwent screening colonoscopy by six ex-
perienced endoscopists at VUH SK. We excluded one 
endoscopist who performed less than 30 colonoscopies 
within the study period, along with his 25 patients. That 
resulted a study sample size of 1633 screening colonos-
copies performed by five endoscopists. The mean age 
of the 1633 patients was 62 years (± 6.8 years), with 
750 men (45.9%) and 883 women (54.1%). Mean 
Table 1. Definitions of measurements
Measurement Definition
Adenoma detection rate 
(ADR, %)
Total number of procedures when ≥1 histologically confirmed adenoma (tubular, tubulovillous, 
villous, serrated) was found divided by the number of all screening procedures
Findings detection rate 
(FDR, %)
Total number of procedures when ≥1 polyp or any other finding despite histology was found 
divided by the number of all screening procedures
Multiple adenoma de-
tection rate (MADR, %)
Total number of procedures when ≥3 histologically confirmed adenomas (tubular, tubulovillous, 
villous, serrated) was found divided by the number of all screening procedures
Mean number of adenoma 
per procedure (MAP, n)
Total number of histologically confirmed adenomas detected divided by the number of all scree-
ning procedures
MAP per positive proce-
dure (MAP+, n)
Total number of histologically confirmed adenomas detected divided by the number of scree-
ning procedures positive for ≥1 adenoma
Cecal intubation rate, % Total number of successful cecal intubations divided by all screening procedures. Cecal intu-
bation was defined as the passage of the colonoscope tip proximal to the ileocecal valve and 
visualization of the entire cecum
Bowel preparation
(subjectively)
1) Good: entire mucosa of bowel seen well 
2) Medium: minor amount of residual staining, small fragments of stool and/or opaque liquid, 
but mucosa is seen well 
3) Poor: unprepared colon segment with mucosa not seen due to solid stool that can not be 
cleared
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number of colonoscopies for one endoscopist was 327 
and ranged from 185 to 723. Number of colonoscopies 
performed by each endoscopist is depicted in Figure 1. 
Cecal intubation was successful in 96.8% of patients. 
Cecal intubation rate was high for all endoscopists, 
ranging from 96.3% to 98.9% and these inter-individ-
ual variations among endoscopists were not statistically 
significant (χ2 (4, N=1633)=3.79, p=0.34) (Figure 2). 
Bowel preparation was good, medium and poor in 
65.2%, 28.1% and 6.7% cases, respectively. As we did 
not used any validated bowel preparation scale, the 
evaluation of bowel preparation quality in our study 
was subjective. Table 2 presents the findings detected by 
their characteristics. 49.9% of screening colonoscopies 
(n=816) were positive (polyps, tumors or any other 
masses were found) and 50.1% (n=817) of screening 
colonoscopies were negative (no findings). There were 
1941 findings detected among 816 of the 1633 screened 
patients. Among all findings, adenomas were the most 
common finding: we found 821 adenomas among 515 
patients (31.5%). Endoscopic findings were more com-
mon in men (Table 3). Men were more likely to have 
polyps than women: adenomas (40.4% vs. 24%; χ2(1, 
N=1633)=50.46, p<0.001); hyperplastic polyps (11.1% 
vs. 6.6% χ2(1, N=1633)=10.401, p=0.001) and mul-
tiple adenomas (6.4% vs. 1.9% χ2(1,N=1633)=21.25, 
p<0.001). Colorectal adenocarcinoma was found in 76 
persons (4.7%) and there was no statistically significant 
difference regarding sex (χ2(2,N=1633)=0.53, p=0.76). 
The overall ADR was 31.5% and 40.4% in men and 
Figure 1. Number of performed colonoscopies by endoscopist Figure 2. Cecal intubation rates 
Table 2. Findings characteristic
Type Patients (n[%])N=1633 Findings (n)
All findings 816(49.9) 1941
All polyps with 
histology
605(37) 1032
Adenocarcinoma 76(4.7) 78
Adenoma 515(31.5) 821
Multiple adenoma 65(4.0) -
Hyperplastic polyp 141(8.6) 211
No findings 817 (50.1) -
Table 3. Findings characteristics between gender groups
Type
All 
subjects 
(n[%]) 
(n=1633)
Men 
(n[%]) 
(n=750)
Women 
(n[%]) 
(n=883)
p value
All findings 816(49.9) 459(61.2) 357(40.3) <0.001
Mean all 
findings
1.19 1.71 0.75 <0.001
Adenoma 515(31.5) 303(40.4) 212(24) <0.001
Mean ade-
noma
0.5 0.69 0.35 <0.001
Hyperplas-
tic polyps
141(8.6) 83(11.1) 58(6.6) 0.001
Mean 
hyperplastic 
polyps
0.13 0.18 0.9 <0.001
Adenocarci-
noma
76(4.7) 38(5.1) 38(4.3) 0.76
Multiple 
adenoma
65(4) 48(6.4) 17(1.9) <0.001
No findings 817(50.1) 291(38.8) 526(59.6) <0.001
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24% in women (χ2(1, N=1633)=50.46, p<0.001). 
ADR ranged among endoscopists from lowest 26.8% 
to highest 36.5% and there was a statistically signifi-
cant difference between endoscopists E1 vs. E4 (χ2(4, 
N=1633)=14.26, p=0.007). The overall FDR was 49.9% 
and ranged among endoscopists from 46.2% to 57.3%; 
there was also a significant difference between endos-
copists E3 vs. E4 (χ2(4, N=1633)=12.75, p=0.013). 
The overall MADR was 4% and ranged from 1.7% to 
6.7%; there was also a statistically significant difference 
among endoscopists E1 vs. E2 (χ2(4, N=1633)=10.73, 
p=0.03). ADR, FDR and MADR rates are shown in 
Figure 3. The overall MAP was 0.5; the overall MAP+ 
was 1.59. MAP ranged from 0.42 to 0.64 and there was 
statistically significant differences between endoscopists 
E1 (MAP 0.62) vs. E4 (MAP 0.42) and E3 (MAP 0.64) 
vs. E4 (MAP 0.42) (F(4.1628)=3.69, p=0.005). While 
MAP+ ranged from 1.38 to 1.78 and there was no 
statistically significant differences among endoscopists 
(F(4.510)=1.49, p=0.2). MAP and MAP+ results are 
shown in Figure 4.
Discussion 
To our knowledge, this is the first report on measuring 
quality indicators for a screening colonoscopy in Lithu-
ania. This study demonstrated high quality screening 
colonoscopy in our centre with a high adenoma detec-
tion rate, which exceeds current recommendations. 
Several studies on ADR have been previously con-
ducted. In the present retrospective study the ADR of 
the total 1633 patients was 31.5%. These results are in 
accordance with adenoma detection rates of 22–58.2% 
reported in large meta-analysis [15]. In the retrospective 
analysis performed by Raju and al ADR was higher and 
reached 60% without serrated lesions and 66% with 
serrated lesions [16]. However, we found total ADR 
(31.5%), ADR in men (40.4%) and ADR in women 
(24%) higher than the minimum benchmarks recom-
mended for screening colonoscopies (total ADR of 
25%, ADR of 30% for men and 20% for women [10]). 
In addition, similar to the results of previous studies, 
the total ADR in men was found to be significantly 
higher, compared with that in women in the present 
study [17–18]. 
In our study MADR was 4%, MAP and MAP+ was 
0.5 and 1.59, respectively. French study retrospectively 
analyzed 42817 colonoscopies and found that endosco-
pists who had an adenoma detection rate around 35% 
had a MAP varying between 0.36 and 0.98 [19]. They 
concluded that MAP could be used as quality indica-
tor for screening colonoscopies at the benchmark 0.6. 
Raju and al study found higher prevalence of adenomas 
comparing to our results: MADR 14% without ser-
rated lesions and 16% with serrated lesions, MAP 1.4 
without serrated lesions and 1.6 with serrated lesions 
Figure 3. Principal measurements rates
Figure 4. Mean number of adenoma per procedure and per 
positive procedure
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and MAP+ 1.9 with serrated lesions [16]. We think 
that some important factors resulted in such different 
ADR, MADR and MAP values, comparing with the 
results of our study. In Raju and al study intense and 
the same for all patients bowel preparation regimen was 
used, while in our study regimen of bowel preparation 
for colonoscopy varied per patient because of different 
schemes proposed for patients by referring family doc-
tors. So we could not influence bowel preparation and 
we had 34.8% of inadequate preparation. Also we did 
not used any bowel preparation evaluation scale. Techni-
cal aspects, as transparent cap, simethicone flush, with-
drawal time minimum 6 minutes has leaded to higher 
values of measurements in the mentioned study. Due to 
retrospective design of our study we could not influence 
these technical aspects. On the other hand, currently 
there is no enough evidence to recommend benchmark 
for MADR, MAP and MAP+ for screening colonoscopy. 
We found some significant differences of the rates of 
our principal measurements among endoscopists and 
these results are in keeping with the results of other 
studies. The clinical impact of such findings regard-
ing the occurrence of interval colorectal cancer is not 
clear and demands further evaluation. Barclay and al 
reported large differences among 12 gastroenterologists 
in the rates of adenoma detection: 10.5-fold in mean 
number of lesions per subject and 3.5-fold in adenoma 
per subject [14]. These differences correlated to colo-
noscope withdrawal time: those endoscopists with 
6 minutes and more had higher neoplasia detection 
rates. Due to retrospective design of our study we had 
no data about colonoscope withdrawal times, so the 
impact of withdrawal time on our principal measures 
was not evaluated. Differences among endoscopists in 
our study were not so large: 1.36-fold in ADR, 3.9-fold 
in MADR, 1.5-fold in MAP and 1.3-fold in MAP+. In 
another study ADR and MADR differences among 18 
endoscopists were also larger comparing to our study: 
ADR ranged from 25.4% to 46.8% (1.84-fold), MADR 
ranged from 2.7% to 12.4% (4.6-fold) [20]. They have 
concluded that endoscopist were independent predictor 
of detecting adenomas. 
In clinical practice, the ADR was also found to be clo-
sely associated with the quality of bowel preparation, the 
cecal intubation rate, the level of operating techniques 
of the endoscopist and the quality of the endoscopic 
devices [17]. Noting that, the present study had certain 
limitations. Some important data (e.g. technical aspects, 
bowel preparation regimen, colonoscope withdrawal 
time) could not be verified due to retrospective design 
of the study. Subjective evaluation of bowel preparation 
quality did not allow us to evaluate how ADR was asso-
ciated with the quality of bowel preparation. Also not 
all polyps detected were evaluated histologically (were 
lost during procedure) and that affected the adenoma 
detection rates. The study was completed in a single 
center and results presented does not reflect a national 
situation. 
In conclusion, in this retrospective study of 1633 
patients, an ADR of 31.5% was calculated which is 
sufcient for reporting high quality screening colonos-
copy in our hospital. Adenomas were found to be more 
prevalent in male compared with female patients. We 
demonstrated that inter-endoscopist variability in ade-
noma detection exists. Further prospective multi-centre 
studies with larger sample size needed to determine qua-
lity of screening colonoscopies in our country. The effect 
of age, bowel preparation, colonoscope withdrawal 
time, different endoscopic innovations on ADR should 
be also evaluated.
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